$NYC
American Strategic Investment Co. Stock $nyc

$nyc Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000159552724000017 Filed on August 09, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$15.45M	$15.75M
YoY Change	-3.58%	-0.18%
Cost Of Revenue	$10.59M	$10.39M
YoY Change	-0.75%	0.45%
Gross Profit	$4.857M	$5.366M
YoY Change	-9.04%	-1.38%
Gross Profit Margin	31.44%	34.06%
Selling, General & Admin	$1.838M	$2.150M
YoY Change	-41.46%	-54.67%
% of Gross Profit	37.84%	40.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.414M	$5.151M
YoY Change	-32.09%	-23.68%
% of Gross Profit	90.88%	95.99%
Operating Expenses	$6.252M	$7.301M
YoY Change	-35.15%	-36.47%
Operating Profit	-$29.21M	-$86.66M
YoY Change	527.0%	1297.28%
Interest Expense	-$5.279M	$5.201M
YoY Change	-211.39%	10.5%
% of Operating Profit
Other Income/Expense, Net	-$5.270M	-$5.192M
YoY Change	11.39%	10.54%
Pretax Income	-$34.48M	-$91.85M
YoY Change	267.22%	742.75%
Income Tax
% Of Pretax Income
Net Earnings	-$34.48M	-$91.85M
YoY Change	267.22%	742.75%
Net Earnings / Revenue	-223.23%	-583.03%
Basic Earnings Per Share	-$13.52	-$36.48
Diluted Earnings Per Share	-$13.52	-$36.48
COMMON SHARES
Basic Shares Outstanding	2.643M shares	2.579M shares
Diluted Shares Outstanding	2.551M	2.518M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.234M	$5.222M
YoY Change	2.63%	-25.95%
Cash & Equivalents	$5.234M	$5.222M
Short-Term Investments
Other Short-Term Assets	$4.353M	$5.642M
YoY Change	-59.69%	1.84%
Inventory
Prepaid Expenses
Receivables	$30.00M	$30.63M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$39.59M	$41.50M
YoY Change	-13.56%	-0.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$456.5M	$541.0M
YoY Change	-35.37%	-24.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$71.79M	$16.42M
YoY Change	319.82%	4.63%
Total Long-Term Assets	$528.3M	$557.4M
YoY Change	-27.06%	-24.03%
TOTAL ASSETS
Total Short-Term Assets	$39.59M	$41.50M
Total Long-Term Assets	$528.3M	$557.4M
Total Assets	$567.9M	$598.9M
YoY Change	-26.26%	-22.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.14M	$15.81M
YoY Change	20.11%	31.27%
Accrued Expenses	$54.61M	$54.63M
YoY Change	-0.17%	-0.11%
Deferred Revenue
YoY Change
Short-Term Debt	$575.0K	$150.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$73.32M	$70.59M
YoY Change	5.04%	5.78%
LONG-TERM LIABILITIES
Long-Term Debt	$396.8M	$396.5M
YoY Change	0.39%	0.39%
Other Long-Term Liabilities	$5.380M	$5.086M
YoY Change	-11.8%	-19.65%
Total Long-Term Liabilities	$402.2M	$401.6M
YoY Change	0.2%	0.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$73.32M	$70.59M
Total Long-Term Liabilities	$402.2M	$401.6M
Total Liabilities	$475.5M	$472.1M
YoY Change	0.92%	0.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$639.2M	-$604.7M
YoY Change	48.17%	43.3%
Common Stock	$26.00K	$26.00K
YoY Change	13.04%	13.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$92.37M	$126.8M
YoY Change
Total Liabilities & Shareholders Equity	$567.9M	$598.9M
YoY Change	-26.26%	-22.77%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$34.48M	-$91.85M
YoY Change	267.22%	742.75%
Depreciation, Depletion And Amortization	$4.414M	$5.151M
YoY Change	-32.09%	-23.68%
Cash From Operating Activities	$2.565M	-$916.0K
YoY Change	926.0%	-73.33%
INVESTING ACTIVITIES
Capital Expenditures	$357.0K	$204.0K
YoY Change	-12.93%	-58.62%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$357.0K	-$204.0K
YoY Change	-12.93%	-58.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	425.0K	150.0K
YoY Change		-1600.0%
NET CHANGE
Cash From Operating Activities	2.565M	-916.0K
Cash From Investing Activities	-357.0K	-204.0K
Cash From Financing Activities	425.0K	150.0K
Net Change In Cash	2.633M	-970.0K
YoY Change	-1745.62%	-75.37%
FREE CASH FLOW
Cash From Operating Activities	$2.565M	-$916.0K
Capital Expenditures	$357.0K	$204.0K
Free Cash Flow	$2.208M	-$1.120M
YoY Change	-1480.0%	-71.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2163524	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2163524	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.77
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-41.09
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	151000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity File Number EntityFileNumber	001-39448
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4380248
CY2023Q4	us-gaap	Land Land	188935000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	56929000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	725129000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	144956000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	580173000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5292000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7516000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54737000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6150000	usd
CY2023Q4	us-gaap	Assets Assets	694172000	usd
CY2023Q4	nycr	Secured Debt Netof Deferred Financing Costs SecuredDebtNetofDeferredFinancingCosts	395702000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	12975000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	54625000	usd
CY2024Q2	us-gaap	Below Market Lease Net BelowMarketLeaseNet	1636000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3450000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2642764	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2642764	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2334340	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	26000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	731491000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-604738000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	126779000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	31316000	usd
	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	3872000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	151000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4504000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22657000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2420385	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2420385	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-10.47
	dei	Entity Address City Or Town EntityAddressCityOrTown	Newport
	dei	Entity Address State Or Province EntityAddressStateOrProvince	RI
	dei	City Area Code CityAreaCode	212
	dei	Local Phone Number LocalPhoneNumber	415-6500
	dei	Entity Central Index Key EntityCentralIndexKey	0001595527
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Address Address Line1 EntityAddressAddressLine1	222 Bellevue Ave.
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02840
CY2024Q2	us-gaap	Land Land	156109000	usd
CY2024Q2	nycr	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	399794000	usd
CY2023Q4	nycr	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	479265000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	37056000	usd
CY2024Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	592959000	usd
CY2024Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	106583000	usd
CY2024Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	486376000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5222000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7907000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54626000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	5642000	usd
CY2024Q2	us-gaap	Derivative Assets DerivativeAssets	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	400000	usd
CY2024Q2	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	30631000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	30752000	usd
CY2024Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	8512000	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	9152000	usd
CY2024Q2	us-gaap	Assets Assets	598916000	usd
CY2024Q2	nycr	Secured Debt Netof Deferred Financing Costs SecuredDebtNetofDeferredFinancingCosts	396465000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	15811000	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Registrant Name EntityRegistrantName	American Strategic Investment Co.
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2642764	shares
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	150000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54657000	usd
CY2023Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	2061000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3983000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	472137000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	469378000	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2334340	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	23000	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2334340	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	23000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	729644000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	729644000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	406000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-505279000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	224794000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	598916000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-505279000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	224794000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	598916000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	694172000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	694172000	usd
CY2024Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	15754000	usd
CY2023Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	15782000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	31235000	usd
CY2024Q2	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	1927000	usd
CY2024Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	15754000	usd
CY2023Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	15782000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	31235000	usd
CY2024Q2	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	1927000	usd
CY2023Q2	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	1988000	usd
CY2023Q2	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	1988000	usd
	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	3830000	usd
CY2024Q2	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8461000	usd
CY2023Q2	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8353000	usd
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	16843000	usd
	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	3830000	usd
CY2024Q2	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8461000	usd
CY2023Q2	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8353000	usd
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	16843000	usd
CY2024Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	84724000	usd
CY2023Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	151000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	186000	usd
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	16774000	usd
CY2024Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	84724000	usd
CY2023Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	151000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	84724000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	186000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2304000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	240000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1964000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2439000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4765000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2304000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1964000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2439000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4765000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5620000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5151000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6749000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10412000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5151000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6749000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10412000	usd
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	102413000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	21984000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-86659000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6202000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-89579000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13701000	usd
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	102413000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	21984000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	120814000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	44622000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-86659000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6202000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-89579000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	5201000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	4707000	usd
	us-gaap	Interest Expense InterestExpense	9898000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13306000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	5201000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	4707000	usd
	us-gaap	Interest Expense InterestExpense	9898000	usd
	us-gaap	Interest Expense InterestExpense	9370000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5192000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5192000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4697000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4697000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9880000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91851000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10899000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-99459000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-52000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-406000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9351000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91851000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10899000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-99459000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-52000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-406000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-434000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-52000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-406000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-434000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-91851000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10951000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-99865000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-434000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-52000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-406000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-434000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-91851000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10951000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-99865000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23091000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2518176	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2518176	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2518176	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2518176	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2286797	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2286797	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-36.48
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-36.48
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-36.48
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-36.48
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.77
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-10.47
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-41.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-10.47
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	224794000	usd
	nycr	Stock Issued During Period Value Issued For Management Fees StockIssuedDuringPeriodValueIssuedForManagementFees	1610000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	240000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	224794000	usd
	nycr	Stock Issued During Period Value Issued For Management Fees StockIssuedDuringPeriodValueIssuedForManagementFees	1610000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	240000	usd
	us-gaap	Profit Loss ProfitLoss	-99459000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-406000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	126779000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	217367000	usd
	us-gaap	Profit Loss ProfitLoss	-99459000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-406000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	126779000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	217367000	usd
CY2024Q2	nycr	Stock Issued During Period Value Issued For Management Fees StockIssuedDuringPeriodValueIssuedForManagementFees	1077000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	186000	usd
CY2024Q2	nycr	Stock Issued During Period Value Issued For Management Fees StockIssuedDuringPeriodValueIssuedForManagementFees	1077000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	186000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-91851000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	126779000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321576000	usd
	nycr	Stock Issued During Period Value Warrants And Rights StockIssuedDuringPeriodValueWarrantsAndRights	4059000	usd
	nycr	Stock Issued During Period Value Issued For Management Fees StockIssuedDuringPeriodValueIssuedForManagementFees	485000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-91851000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	126779000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321576000	usd
	nycr	Stock Issued During Period Value Warrants And Rights StockIssuedDuringPeriodValueWarrantsAndRights	4059000	usd
	nycr	Stock Issued During Period Value Issued For Management Fees StockIssuedDuringPeriodValueIssuedForManagementFees	485000	usd
	nycr	Stock Redeemed During Period Value StockRedeemedDuringPeriodValue	24000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4504000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	10000	usd
	us-gaap	Profit Loss ProfitLoss	-22657000	usd
	nycr	Stock Redeemed During Period Value StockRedeemedDuringPeriodValue	24000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4504000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	10000	usd
	us-gaap	Profit Loss ProfitLoss	-22657000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-434000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-434000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	307499000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	316156000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	307499000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	316156000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	10000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-10899000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-52000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2304000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	10000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-10899000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-52000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	307499000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-99459000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22657000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	307499000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-99459000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22657000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10412000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13701000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10412000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13701000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	763000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	771000	usd
	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	112000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	763000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	771000	usd
	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	112000	usd
	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	9000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	240000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4504000	usd
	nycr	Management Fees Reinvested ManagementFeesReinvested	1610000	usd
	nycr	Management Fees Reinvested ManagementFeesReinvested	485000	usd
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-123000	usd
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	84000	usd
	nycr	Increase Decreasein Straight Line Rent Payable IncreaseDecreaseinStraightLineRentPayable	54000	usd
	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	9000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	240000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4504000	usd
	nycr	Management Fees Reinvested ManagementFeesReinvested	485000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	84724000	usd
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-123000	usd
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	84000	usd
	nycr	Increase Decreasein Straight Line Rent Payable IncreaseDecreaseinStraightLineRentPayable	54000	usd
	nycr	Increase Decreasein Straight Line Rent Payable IncreaseDecreaseinStraightLineRentPayable	54000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-260000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	471000	usd
	nycr	Increase Decreasein Straight Line Rent Payable IncreaseDecreaseinStraightLineRentPayable	54000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-260000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	471000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2657000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-246000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2657000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-246000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-533000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-376000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	739000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4177000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	568000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-533000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-376000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	739000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4177000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	568000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	2801000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-568000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2801000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	150000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	2801000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-568000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2801000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	150000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4059000	usd
	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	0	usd
	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	24000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	150000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4025000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	321000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2953000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12808000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16117000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13129000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4059000	usd
	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	0	usd
	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	24000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	150000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4025000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	321000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2953000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12808000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16117000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13129000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13164000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5222000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7052000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7907000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13164000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5222000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7052000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7907000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6112000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13129000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6112000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13164000	usd
	us-gaap	Interest Paid Net InterestPaidNet	9033000	usd
	us-gaap	Interest Paid Net InterestPaidNet	8550000	usd
	nycr	Increase Decrease In Accrued Capital Expenditures IncreaseDecreaseInAccruedCapitalExpenditures	180000	usd
	nycr	Increase Decrease In Accrued Capital Expenditures IncreaseDecreaseInAccruedCapitalExpenditures	496000	usd
	us-gaap	Stock Issued1 StockIssued1	1610000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13164000	usd
	us-gaap	Interest Paid Net InterestPaidNet	9033000	usd
	us-gaap	Interest Paid Net InterestPaidNet	8550000	usd
	nycr	Increase Decrease In Accrued Capital Expenditures IncreaseDecreaseInAccruedCapitalExpenditures	180000	usd
	nycr	Increase Decrease In Accrued Capital Expenditures IncreaseDecreaseInAccruedCapitalExpenditures	496000	usd
	us-gaap	Stock Issued1 StockIssued1	1610000	usd
	us-gaap	Stock Issued1 StockIssued1	485000	usd
CY2024Q2	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	7	property
CY2024Q2	us-gaap	Net Rentable Area NetRentableArea	1200000	sqft
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.125
	us-gaap	Stock Issued1 StockIssued1	485000	usd
CY2024Q2	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	7	property
CY2024Q2	us-gaap	Net Rentable Area NetRentableArea	1200000	sqft
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.125
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, and fair value measurements, as applicable.</span></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, and fair value measurements, as applicable.</span></div>
	nycr	Lessor Operating Lease Weighted Average Remaining Lease Term LessorOperatingLeaseWeightedAverageRemainingLeaseTerm	P6Y3M18D
	nycr	Lessor Operating Lease Weighted Average Remaining Lease Term LessorOperatingLeaseWeightedAverageRemainingLeaseTerm	P6Y3M18D
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	84700000	usd
CY2024Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	84700000	usd
CY2023Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	200000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	200000	usd
CY2024Q2	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	583800000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	84700000	usd
CY2024Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	84700000	usd
CY2023Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	200000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	200000	usd
CY2024Q2	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	583800000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	49500000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	99000000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	140000000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	60000000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	51000000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	usd
CY2024Q2	us-gaap	Secured Debt SecuredDebt	399500000	usd
CY2024Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	400000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	49500000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	99000000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	140000000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	60000000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	51000000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	usd
CY2024Q2	us-gaap	Secured Debt SecuredDebt	399500000	usd
CY2024Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	400000	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	400000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	400000	usd
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2600000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2300000	shares
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P42Y6M
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.086
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54600000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	54600000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2400000	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	2400000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	2400000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2373000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4746000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4746000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4746000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4746000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	4746000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	183516000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	209619000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	154994000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	54625000	usd
	nycr	Advisory Agreement Renewal Term AdvisoryAgreementRenewalTerm	P5Y
CY2018Q4	nycr	Period Prior To Expiration Date Needed To Terminate Agreement PeriodPriorToExpirationDateNeededToTerminateAgreement	P180D
CY2023Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	400000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	400000	usd
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2600000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2300000	shares
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P42Y6M
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.086
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54600000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	54600000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2400000	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	2400000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2400000	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	2400000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2373000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4746000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4746000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4746000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4746000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	4746000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	183516000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	209619000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	154994000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	54625000	usd
	nycr	Advisory Agreement Renewal Term AdvisoryAgreementRenewalTerm	P5Y
CY2018Q4	nycr	Period Prior To Expiration Date Needed To Terminate Agreement PeriodPriorToExpirationDateNeededToTerminateAgreement	P180D
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	150000	usd
CY2024Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	3005000	usd
CY2023Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	3155000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	6300000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	6400000	usd
CY2020Q3	nycr	Equity Based Compensation Consecutive Trading Days EquityBasedCompensationConsecutiveTradingDays	30	trading_day
CY2020Q3	nycr	Equity Based Compensation Consecutive Trading Days EquityBasedCompensationConsecutiveTradingDays	10	trading_day
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4200000	usd
	nycr	Distributions On The Ltip Unit DistributionsOnTheLTIPUnit	0.10
	nycr	Distribution On The Earned Ltip Unit DistributionOnTheEarnedLTIPUnit	0.90
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	150000	usd
CY2024Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	3005000	usd
CY2023Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	3155000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	6300000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	6400000	usd
CY2020Q3	nycr	Equity Based Compensation Consecutive Trading Days EquityBasedCompensationConsecutiveTradingDays	30	trading_day
CY2020Q3	nycr	Equity Based Compensation Consecutive Trading Days EquityBasedCompensationConsecutiveTradingDays	10	trading_day
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4200000	usd
	nycr	Distributions On The Ltip Unit DistributionsOnTheLTIPUnit	0.10
	nycr	Distribution On The Earned Ltip Unit DistributionOnTheEarnedLTIPUnit	0.90
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91851000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10899000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-99459000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22657000	usd
CY2024Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-91851000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10899000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-99459000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-22657000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2518176	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2518176	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2286797	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2286797	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2420385	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2420385	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2163524	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2163524	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-36.48
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-36.48
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.77
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-41.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-41.09
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	56590	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	518004	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	45807	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	519846	shares
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91851000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10899000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-99459000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22657000	usd
CY2024Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-91851000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10899000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-99459000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-22657000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2518176	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2518176	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2286797	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2286797	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2420385	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2420385	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2163524	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2163524	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-36.48
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-36.48
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.77
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-41.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-41.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-10.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-10.47
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	56590	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	518004	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	45807	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	519846	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001595527-24-000017-index-headers.html	Edgar Link	pending
0001595527-24-000017-index.html	Edgar Link	pending
0001595527-24-000017.txt	Edgar Link	pending
0001595527-24-000017-xbrl.zip	Edgar Link	pending
ex311asic6302024.htm	Edgar Link	pending
ex312asic6302024.htm	Edgar Link	pending
ex32asic6302024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nycr-20240630.htm	Edgar Link	pending
nycr-20240630.xsd	Edgar Link	pending
nycr-20240630_g1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nycr-20240630_cal.xml	Edgar Link	unprocessable
nycr-20240630_lab.xml	Edgar Link	unprocessable
nycr-20240630_def.xml	Edgar Link	unprocessable
nycr-20240630_pre.xml	Edgar Link	unprocessable
nycr-20240630_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NYC
American Strategic Investment Co. Stock $nyc

2024 Q3 Form 10-Q Financial Statement

#000159552724000017 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC American Strategic Investment Co. Stock $nyc

2024 Q3 Form 10-Q Financial Statement

#000159552724000017 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC
American Strategic Investment Co. Stock $nyc